Teva Pharmaceutical Industries Ltd (TEVA) Q3 2022 Earnings Call
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q3 2022 Earnings Conference
Teva Pharmaceutical Industries Ltd (TEVA) Q2 2022 earnings call
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 2022 Earnings Conference
Teva Pharmaceutical Industries Ltd (TEVA) Q1 2022 earnings call
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q1 2022 Earnings Conference
AlphaGraphs
Teva Pharmaceutical (TEVA) bets on market reopening to regain momentum
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), a market leader in generic drugs, reported lower revenues for the third quarter of 2021, citing a slowdown in…
Teva Pharmaceutical Industries Ltd (TEVA) Teva to Host Conference Call to Discuss Third Quarter 2021 Financial Results
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q3 2021 Earnings Conference
Teva Pharmaceutical Industries Ltd (TEVA) Q2 2021 Earnings Call Transcript
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 2021 earnings call dated Jul. 28, 2021. Corporate Participants: Kevin C. Mannix — Senior Vice President, Head of Investor…
Teva Pharmaceutical Industries Ltd (TEVA) Teva to Host Conference Call to Discuss Second Quarter 2021 Financial Results
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 2021 Earnings Conference
AlphaGraphs
Infographic: Teva Pharmaceuticals (TEVA) Q1 2021 earnings results
Teva Pharmaceuticals’ (NYSE: TEVA) reported first-quarter 2021 results today before the opening bell. The company dropped its revenue by 9% to $3.98 billion year on…
Teva Pharmaceuticals (TEVA) Q2 2020 earnings: Reaffirms FY20 outlook
Teva Pharmaceuticals (NYSE: TEVA) beat Q2 earnings estimates, but fell short of Street’s revenue targets. The drug manufacturer reported adjusted EPS of $0.53 on revenue…
Teva Pharmaceutical Industries Limited (NYSE: TEVA) Q1 2020 Earnings Call Transcript
Teva Pharmaceutical Industries Limited (TEVA) Q1 2020 earnings call dated May 07, 2020 Corporate Participants: Kevin C. Mannix — Senior Vice President, Investor Relations Kare Schultz — Director and…